Open AccessPB2083: STUDY CONDUCT AND PATIENT SAFETY DURING THE COVID‐19 PANDEMIC: OBSERVATIONS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA FROM THE GAZELLE TRIAL OF OBINUTUZUMAB SHORT DURATION INFUSION
Author(s) -
Canales M. A.,
Buchholz T. A.,
Ishikawa T.,
Fogliatto L. M.,
Bortolini J.,
Capote Huelva F. J.,
Salar A.,
Tucker D.,
Vorozheikina E.,
Klingbiel D.,
Pokala S.,
Parreira J.,
Nick S.,
Hübel K.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851164.46525.3c
Subject(s) - obinutuzumab , medicine , vincristine , cyclophosphamide , oncology , surgery , lymphoma , rituximab , chemotherapy